Longitude Capital is a venture capital firm that specializes in investments in biotechnology, medical technology, and health solutions. Founded in 2006 and based in Menlo Park, California, with an additional office in Boston, Massachusetts, the firm has raised over $2 billion across six funds and manages approximately $1.7 billion in assets. The firm focuses on improving clinical outcomes and enhancing patient quality of life while reducing healthcare costs. Longitude Capital invests in both privately held and publicly traded companies, utilizing various investment structures. Beyond providing capital, the firm offers strategic guidance and mentorship to its portfolio companies, assisting them in achieving key objectives and building strong teams. With a team that has over 200 years of combined experience in life sciences, Longitude Capital has made over 90 new investments and 150 follow-on investments, leveraging a broad industry network and proprietary research capabilities to identify emerging opportunities in healthcare.
我们正在追踪 Longitude Capital 的市场扩张
Longitude Capital 的国际扩张与竞争对手的对比情况
Longitude Capital你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Longitude Capital你 | 0 | 0 | — | 0 | 0 |
当前没有招聘
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
没有进行中的营销活动
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
海思科医药将HSK39004全球权利授权给AirNexis，交易总额高达10.63亿美元，标志着中国呼吸领域创新药国际化的重要突破。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Longitude Capital 的业务、市场和增长信号的快速解答。
